Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma

Affiliations

• ¹ Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
• ² Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
• ³ Department of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ⁴ Department of Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), University Hospital Heidelberg and CCU Neuropathology, Heidelberg, Germany.
• ⁵ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ⁶ Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
• ⁷ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ⁸ Institute of Neuropathology, Justus-Liebig-University, Gießen, Germany.
• ⁹ Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
• ¹⁰ Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
• ¹¹ Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany.
• ¹² Clinical Cooperation Unit Neurooncology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ¹³ Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
• ¹⁴ Department of Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), University Hospital Heidelberg and CCU Neuropathology, Heidelberg, Germany. [email protected].